Entia Biosciences, Inc. 4
4 · Entia Biosciences, Inc. · Filed Dec 6, 2016
Insider Transaction Report
Form 4
HAUSMAN MARVIN S MD
DirectorCEO10% Owner
Transactions
- Purchase
Warrant
2016-12-05+40,000→ 40,000 totalExercise: $0.10From: 2016-12-05Exp: 2021-12-05→ Common Stock (40,000 underlying) - Purchase
10% Convertible
2016-12-05$10000.00/shFrom: 2016-12-05Exp: 2017-12-05→ Common Stock
Footnotes (2)
- [F1]Holder has option of repayment or conversation into securities of the subject company's next financing. Terms and underlying securities of next financing, if and when such financing occurs, have yet to be determined.
- [F2]As part of Unit.